The code block below illustrates how one might use # and // as comments in your logic and calculations.

This value you provided is not a number. Please try again.

This value you provided is not an integer. Please try again.

The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again.

The value you provided must be within the suggested range

The value you provided is outside the suggested range

This value is admissible, but you may wish to double check it.

The value entered must be a time value in the following format HH:MM within the range 00:00-23:59 (e.g., 04:32 or 23:19).

This field must be a 5 or 9 digit U.S. ZIP Code (like 94043). Please re-enter it now.

This field must be a 10 digit U.S. phone number (like 415 555 1212). Please re-enter it now.

This field must be a valid email address (like joe@user.com). Please re-enter it now.

The value you provided could not be validated because it does not follow the expected format. Please try again.

Required format:

Landscape of Opioid Programs

Returning?

A A A

Dear CTSA Program PIs,

The goal of landscape analysis, created by the Opioid Working Group of the CTSA Program Steering Committee, is to generate a broad landscape analysis of current Opioid-Related programs (representing either best practices or innovative programs) that are underway across the CTSA Hubs / institutions / universities, individually and with diverse partners.

Please note: Your participation is voluntary. Your responses will not be anonymous. Your name and/or your hub's / university's name will be identified for purposes of analysis and dissemination because these results will be used to help identify models to disseminate, opportunities for collaborations and gaps to address (and to form the basis for a manuscript).

The responses to this data collection instrument are voluntary. This data collection instrument will analyze the outcomes in a systematic way and will publicize the results of the systematic analyses at a future date. The systematic results of this data collection instrument will be provided on behalf of CLIC. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Center for Advancing Translational Sciences.

Following publication, the Coordinating Center will post data from this data collection instrument onto the Coordinating website with hub / university identified information so that your hub / university can be credited with your available resources to encourage collaboration.

We request that you complete this data collection instrument on or before Monday, April 30, 2018.

Please complete this landscape analysis yourself or forward (copying us) to the person you believe to be the most knowledgeable to complete it. We request only one response per institution. For your convenience, a "Save and Return" feature is provided in case multiple persons are needed for completion. It is estimated that these questions may be completed by PI/Admin/Other in 25-30 minutes total.

If there are any questions regarding the vetting of this survey please contact Scott McIntosh, PhD, CLIC, at scott_mcintosh@urmc.rochester.edu.

Thank you for your time!

CLIC

1. Hub
Hub responses are requested for tracking, identification of best practices, and for identification of potential collaborations.

* must provide value

If "Other" please specify:

2a. Your Name
Your name is requested for tracking, identification of best practices, and for identification of potential collaborations.

* must provide value

2b Your E-Mail
Your e-mail is requested for tracking, identification of best practices, and for identification of potential collaborations.

* must provide value

3. Identify yourself:

Administrator

Other

reset

If "Other", please specify:

4.a. Does your Hub have any ongoing translational programs focused on OUD (Opioid Use Disorder) and/or overdose?
Translational programs help move basic research into therapeutics.

Yes

reset

4.b. Please list and describe any program that represents a best practice or that provides an innovative approach:

Expand

5.a. Does your Hub currently conduct research and development of chronic pain treatments?

Yes

reset

5.b. Please describe the innovations or best practices in this line of research and development at your Hub:

Expand

6.a. Have you developed effective approaches to affect the use of clinical data to address OUD and/or Overdose?
(e.g., methods and tools to support epidemiological and observational studies, analyzing prescribing patterns, etc.)?

Yes

reset

6.b. Please describe any approaches that serve as best practices or new innovations:

Expand

WORKFORCE/IMPLEMENTATION

Now we'd like to ask you about your training approaches to assessing and addressing high-risk use of opioids within the medical setting.

7.a. Do you train health care providers at your Hub in assessing high-risk use of opioids within the medical setting? (This includes treatment option awareness and prescription)

Yes (Physicians only)

Yes (Other health care providers only)

Yes (Both)

reset

7.b. Do you train health care providers at your Hub in addressing high-risk use of opioids within the medical setting? (This includes treatment option awareness and prescription)

Yes (Physicians only)

Yes (Other health care providers only)

Yes (Both)

reset

7.c. What training approaches do these programs utilize that you would consider best practices or innovative approaches?

Expand

MODEL OF CARE

8.a. Have you identified specific models of care that you have implemented as best practices for different patient groups?

Yes

reset

8.b. Have you identified specific models of care that you have implemented as best practices for different provider settings?

Yes

reset

8.c. Please describe these models of care: for different patient groups and/or provider settings.

Expand

TEAM SCIENCE

9. What models have you utilized to advance collaborations and team science to address OUD and/or Overdose?

Expand

10.a. Are you involved in any existing collaborations in OUD and/or Overdose?

Yes-within the CTSA network

Yes-with other NIH ICs

Yes-with other other government agencies

Yes-with others

10.b. Please describe the type of collaboration - including how they are interdisciplinary (when applicable) - and please list the names of the collaborating institutions:

Expand

CLINICAL RESEARCH

11.a. Have you developed any innovative approaches or best practices to make identification, recruitment and/or retention of populations with OUD more effective?

Yes

reset

11.b. Please describe these approaches: and/or best practices.

Expand

12.a. Are you engaged in any robust clinical trial networks that could potentially be utilized for specific populations (even if not currently utilized for OUD)? Note: If "Yes", check which of these areas might be included in the networks such as:

No (or N/A)

Ob-Gyn

Neonatal

Surgical

Adolescent medicine

Pain management

Primary care

Sickle cell

Other

If "Other", please specify:

12.b. Please briefly describe this (these) network(s):

Expand

COMMUNITY ENGAGEMENT/OTHER

13.a. Please describe any other innovative programs and/or best practices to highlight, including any community engagement or outreach programs not mentioned above. (And please provide links to any of your programs you'd like to share):

Expand

14. Does your hub actively partner with Emergency Departments, Departments of Public Health (or relevant/similar) or a Primary Care Provider Setting/Network and, if so, what activities are happening in these settings related to the opioid crisis?

Expand

DOCUMENT UPLOAD 1: For your convenience, please upload any additional information you wish to provide such as Word or PDF documents, training materials, powerpoints, photos, etc.

Upload file

DOCUMENT UPLOAD 2: If desired.

Upload file

DOCUMENT UPLOAD 3: If desired. If you have more than three documents, please contact us.

Upload file

THANK YOU!

You have selected an option that triggers this survey to end right now.

To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.